We believe that the time to start ADT depends on many variables such as patients’ demands, preferences/experience of physicians, PSA DT, etc. In addition, ADT usually leads to a reduction of PSA levels and can also reduce the tumour size [33, 34]. Here, KLK3 is linked to neoplasm.